Search research articles
Contact Us
Filters
Showing results (281-290 of 303) with videos related to
Page
of 31
Sort By:
Plos One
|
July 7, 2025
A protocol for the evaluation of the PneumoWave biosensor in supported accommodation settings: A study on feasibility and acceptability (RESCU-2)
Basak Tas, Lewis Beer, Elizabeth Appiah-Kusi, et al.
Cannabis and Cannabinoid Research
|
December 9, 2022
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study
Lucy A Chester, Amir Englund, Edward Chesney, et al.
BMJ Open
|
August 3, 2024
Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost
Craig Rodgers, Krista J Siefried, Alison Ritter, et al.
The Lancet. Global Health
|
October 28, 2017
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
Sarah Larney, Amy Peacock, Janni Leung, et al.
Drug and Alcohol Review
|
June 3, 2025
Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia
Jake Rance, Vendula Belackova, James Bell, et al.
BMC Public Health
|
April 18, 2015
Linked randomised controlled trials of face-to-face and electronic brief intervention methods to prevent alcohol related harm in young people aged 14-17 years presenting to Emergency Departments (SIPS junior)
Paolo Deluca, Simon Coulton, M Fasihul Alam, et al.
Contemporary Clinical Trials Communications
|
January 8, 2020
Telephone delivered incentives for encouraging adherence to supervised methadone consumption (TIES): Study protocol for a feasibility study for an RCT of clinical and cost effectiveness
Nicola Metrebian, Timothy Weaver, Stephen Pilling, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 23, 2025
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
Edward Chesney, Dominic Oliver, Ananya Sarma, et al.
Pilot and Feasibility Studies
|
May 20, 2020
A study protocol to assess the feasibility of conducting an evaluation trial of the ADVANCE integrated intervention to address both substance use and intimate partner abuse perpetration to men in substance use treatment
Gail Gilchrist, Sabine Landau, Polly Radcliffe, et al.
Journal of Public Health (Oxford, England)
|
March 29, 2018
Opportunistic screening for alcohol use problems in adolescents attending emergency departments: an evaluation of screening tools
Simon Coulton, M Fasihul Alam, Sadie Boniface, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 303) with videos related to
Sort By:
Page
of 31
Plos One
|
July 7, 2025
A protocol for the evaluation of the PneumoWave biosensor in supported accommodation settings: A study on feasibility and acceptability (RESCU-2)
Basak Tas, Lewis Beer, Elizabeth Appiah-Kusi, et al.
Cannabis and Cannabinoid Research
|
December 9, 2022
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study
Lucy A Chester, Amir Englund, Edward Chesney, et al.
BMJ Open
|
August 3, 2024
Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost
Craig Rodgers, Krista J Siefried, Alison Ritter, et al.
The Lancet. Global Health
|
October 28, 2017
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
Sarah Larney, Amy Peacock, Janni Leung, et al.
Drug and Alcohol Review
|
June 3, 2025
Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia
Jake Rance, Vendula Belackova, James Bell, et al.
BMC Public Health
|
April 18, 2015
Linked randomised controlled trials of face-to-face and electronic brief intervention methods to prevent alcohol related harm in young people aged 14-17 years presenting to Emergency Departments (SIPS junior)
Paolo Deluca, Simon Coulton, M Fasihul Alam, et al.
Contemporary Clinical Trials Communications
|
January 8, 2020
Telephone delivered incentives for encouraging adherence to supervised methadone consumption (TIES): Study protocol for a feasibility study for an RCT of clinical and cost effectiveness
Nicola Metrebian, Timothy Weaver, Stephen Pilling, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 23, 2025
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
Edward Chesney, Dominic Oliver, Ananya Sarma, et al.
Pilot and Feasibility Studies
|
May 20, 2020
A study protocol to assess the feasibility of conducting an evaluation trial of the ADVANCE integrated intervention to address both substance use and intimate partner abuse perpetration to men in substance use treatment
Gail Gilchrist, Sabine Landau, Polly Radcliffe, et al.
Journal of Public Health (Oxford, England)
|
March 29, 2018
Opportunistic screening for alcohol use problems in adolescents attending emergency departments: an evaluation of screening tools
Simon Coulton, M Fasihul Alam, Sadie Boniface, et al.
Page
of 31